Insulin and oral antidiabetic agents for treatment of polycystic ovary syndrome

Simple item page
dc.contributor.authorKuscu, NK
dc.contributor.authorKoyuncu, FM
dc.date.accessioned2024-07-18T11:49:49Z
dc.date.available2024-07-18T11:49:49Z
dc.description.abstractInsulin plays a major role in polycystic ovary syndrome (PCOS). Insulin resistance and resultant hyperinsulinemia stimulate both the ovary and adrenal to produce androgens. Oral antidiabetic agents have been used to alleviate the symptoms and to induce ovulation in women with PCOS. This review focuses on the relation between insulin and PCOS and discusses the use of oral antidiabetic agents.
dc.identifier.issn1521-2076
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/4308
dc.language.isoEnglish
dc.publisherMEDSCAPE INC
dc.subjectGONADOTROPIN-RELEASING-HORMONE
dc.subjectFOLLICLE-STIMULATING-HORMONE
dc.subjectIMPAIRED GLUCOSE-TOLERANCE
dc.subjectOBESE WOMEN
dc.subjectMETFORMIN THERAPY
dc.subjectP450C17-ALPHA ACTIVITY
dc.subjectHYPERANDROGENIC WOMEN
dc.subjectACANTHOSIS NIGRICANS
dc.subjectLUTEINIZING-HORMONE
dc.subjectDIABETES-MELLITUS
dc.titleInsulin and oral antidiabetic agents for treatment of polycystic ovary syndrome
dc.typeReview

Files

Collections

Web of Science Koleksiyonu